Search

everythinglearnresearchcommunity

for

Search:↓

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

Oral retinoids are effective for various skin conditions but have side effects and should not be used during pregnancy.

Some medications can cause reversible hair loss by affecting hair growth cycles.

Skin fungal infections are more common in older adults due to factors like obesity, poor circulation, reduced mobility, and weakened immune defenses from certain medications.

Topoisomerase inhibitors can cause hair loss, skin rash, hand-foot syndrome, and nail changes.

Taking selenium supplements during chemotherapy may help reduce side effects and improve health markers in ovarian cancer patients.

Anticancer drugs are increasingly found in surface waters, and their long-term environmental effects are not well understood, requiring better testing methods.

Telogen effluvium is a hair loss condition with acute cases resolving quickly and chronic cases potentially lasting longer, sometimes requiring treatment.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

Hairgain® significantly increased hair growth and was well-tolerated by individuals with hair loss.

Nourkrin® significantly increased hair growth and was well-tolerated by people with hair loss.

Hormonal differences affect male pattern baldness.

Chemotherapy-induced hair loss significantly affects patients' well-being, and nurses are key in helping them cope, but more research is needed to find effective treatments.

The document concludes that understanding hair structure is key to diagnosing hair abnormalities and recommends gentle hair care for management.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Minoxidil effectively treats female pattern hair loss.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

Birth control pills help treat skin and hair growth problems linked to high male hormone levels.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

Scalp cooling can prevent hair loss in 65% of chemotherapy patients, especially effective in breast cancer patients and certain chemotherapy types.

Liposomes show promise in cancer treatment by delivering drugs with less toxicity and improved effectiveness.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Hair and scalp pain is more common and severe in breast cancer patients on chemotherapy than those on tamoxifen.

Use some skin medications with caution during pregnancy; avoid strong steroids, certain eczema treatments, and systemic retinoids, but many topical treatments and nasal sprays are safe.

Scalp hypothermia can prevent chemotherapy-induced hair loss but is not suitable for all patients, and more research is needed to improve prevention methods.

Use trichoscopy to diagnose hair loss; treat with minoxidil, finasteride, or dutasteride; consider platelet-rich plasma and spironolactone.